Skip to main content
. 2021 Feb 12;21:87. doi: 10.1186/s12872-021-01860-7

Table 2.

Baseline blood biochemistry and Doppler-echocardiography

All (n = 498) CC (n = 358) CT/TT (n = 140) P for difference
Doppler-echocardiography
 EF, median [IQR] 66 [61:70] 66 [61:71] 64 [60:69] 0.005
 E', median [IQR] 8.1 [6.5:10.0] 8.2 [6.7:10.0] 8.1 [6.4:10.0] ns
 E/E’, median [IQR] 8.4 [6.8:10.4] 8.5 [6.7:10.5] 8.4 [7.0:10.4] ns
 LAVI, median [IQR] 24.6 [20.9:30.1] 24.5 [20.6:30.1] 24.8 [21.5:30.1] ns
 LVMI, median [IQR] 92 [80:108] 92 [80:108] 93 [79:109] ns
Baseline prevalence of LVD
 LVDD, n (%) 301 (60.4) 211 (58.9) 90 (64.3) ns
 LVSD, n (%) 24 (4.8) 15 (4.2) 9 (6.4) ns
 Any LVD, n (%) 312 (62.7) 217 (60.6) 95 (67.9) ns
 Any elevated LAVI, n (%) 97 (19.5) 75 (20.9) 22 (14.3) ns
 Any LVH, n (%) 71 (14.2) 49 (13.7) 22 (15.7) ns

IQR interquartile range, EF ejection fraction, LA left atrium, E’ tissue Doppler early diastolic mitral annular tissue velocity at the lateral wall, E/e’ ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity, LVMI left ventricular mass index, LAVI left atrial volume index, LVD left ventricular dysfunction, LVDD left ventricular diastolic dysfunction, LVSD left ventricular systolic dysfunction